160 related articles for article (PubMed ID: 21863320)
1. Correlation of angiographic late loss with neointimal coverage of drug-eluting stent struts on follow-up optical coherence tomography.
Kim BK; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Aug; 28(6):1289-97. PubMed ID: 21863320
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography derived cut-off value of uncovered stent struts to predict adverse clinical outcomes after drug-eluting stent implantation.
Won H; Shin DH; Kim BK; Mintz GS; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2013 Aug; 29(6):1255-63. PubMed ID: 23615849
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation.
Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Dec; 28(8):1887-94. PubMed ID: 22447206
[TBL] [Abstract][Full Text] [Related]
4. Thin-cap fibroatheroma and large calcification at the proximal stent edge correlate with a high proportion of uncovered stent struts in the chronic phase.
Ueda T; Uemura S; Watanabe M; Dote Y; Goryo Y; Sugawara Y; Soeda T; Okayama S; Kawata H; Kawakami R; Okura H; Saito Y
Coron Artery Dis; 2016 Aug; 27(5):376-84. PubMed ID: 27164267
[TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation.
Kim JS; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Aug; 28(6):1281-7. PubMed ID: 21858655
[TBL] [Abstract][Full Text] [Related]
6. Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study.
Giglioli C; Formentini C; Romano SM; Cecchi E; Baldereschi GJ; Landi D; Chiostri M; Prati F; Marchionni N
Int J Cardiovasc Imaging; 2020 Feb; 36(2):217-230. PubMed ID: 31667661
[TBL] [Abstract][Full Text] [Related]
7. Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation.
Kim BK; Kim JS; Oh C; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Apr; 28(4):705-14. PubMed ID: 21626042
[TBL] [Abstract][Full Text] [Related]
8. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
[TBL] [Abstract][Full Text] [Related]
10. Very long-term follow-up of strut apposition and tissue coverage with Biolimus A9 stents analyzed by optical coherence tomography.
Staico R; Costa MA; Chamié D; Bezerra H; Armaganijan LV; Costa RA; Costa JR; Siqueira D; Centemero M; Chaves Á; Tanajura LF; Abizaid A; Feres F; Sousa JE; Sousa AG
Int J Cardiovasc Imaging; 2013 Jun; 29(5):977-88. PubMed ID: 23456358
[TBL] [Abstract][Full Text] [Related]
11. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
[TBL] [Abstract][Full Text] [Related]
12. Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results.
Kim TH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2011 Jul; 27(6):875-81. PubMed ID: 20978851
[TBL] [Abstract][Full Text] [Related]
13. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
[TBL] [Abstract][Full Text] [Related]
14. Impact of underlying plaque type on strut coverage in the early phase after drug-eluting stent implantation.
Kakizaki R; Minami Y; Hashikata T; Nemoto T; Hashimoto T; Fujiyoshi K; Meguro K; Shimohama T; Tojo T; Ako J
Coron Artery Dis; 2018 Dec; 29(8):624-631. PubMed ID: 29975201
[TBL] [Abstract][Full Text] [Related]
15. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
[TBL] [Abstract][Full Text] [Related]
16. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
[TBL] [Abstract][Full Text] [Related]
17. An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents.
Legutko J; Gil RJ; Buszman PE; Kaluza GL; Mintz GS; Roleder T; Krol M; Wojdyla R; Pawlowski T; Brzezinski M; Kondys M; Skwarna B; Jakala J; Zasada W; Partyka L; Dudek D
Catheter Cardiovasc Interv; 2018 Aug; 92(2):302-309. PubMed ID: 29027737
[TBL] [Abstract][Full Text] [Related]
18. Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.
Ohtani H; Kimura S; Sugiyama T; Hishikari K; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hikita H; Ashikaga T; Takahashi A; Isobe M
Int J Cardiovasc Imaging; 2017 Feb; 33(2):177-186. PubMed ID: 27761750
[TBL] [Abstract][Full Text] [Related]
19. One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study.
Shiratori Y; Brugaletta S; Alvarez-Contreras L; Azpeitia Y; Ospino N; Gaido S; Delahanty A; Santos A; Martin-Yuste V; Masotti M; Serruys PW; Windecker S; Sabaté M
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E428-36. PubMed ID: 23441068
[TBL] [Abstract][Full Text] [Related]
20. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.
Choi HH; Kim JS; Yoon DH; Hong KS; Kim TH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Mar; 28(3):491-7. PubMed ID: 21442265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
